Rituximab for the Treatment of Primary Membranous Nephropathy: CADTH Health Technology Review [Internet].
Authors; Islam S, Janoudi G, Bryan M, Perras C, Jabr M, Haines A, Assasi N, Boucher J, Hafizi D, Lafleur P, Black C, Cornelissen, T, Ford C.
Authors, et al. Among authors: jabr m.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Apr.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Apr.
PMID: 38232188
Free Books & Documents.
Review.
No abstract available.